157 related articles for article (PubMed ID: 30486541)
1. [Study on mechanism of Drynariae Rhizoma in treating osteoporosis with integrative pharmacology perspective].
Zhang YL; Tang B; Jiang JJ; Shen H; Xie YM; Wei X
Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(20):4125-4131. PubMed ID: 30486541
[TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.
Gan D; Xu X; Chen D; Feng P; Xu Z
Med Sci Monit; 2019 Aug; 25():5700-5716. PubMed ID: 31368456
[TBL] [Abstract][Full Text] [Related]
3. Study on the Mechanism of Treating Femoral Head Necrosis with Drynariae Rhizoma Based on Network Pharmacology.
He L; Ma C; Cai S; Hou R; Xu H; Liu J; Liu X; Huang Q
Comput Math Methods Med; 2022; 2022():3631722. PubMed ID: 35707043
[TBL] [Abstract][Full Text] [Related]
4. [Research progress on chemical compositions and pharmacological action of Drynariae Rhizoma].
Chen SQ; Liang W; Zhang XM; Li X; Zhan ZL; Guo LP; Huang LQ; Zhang XM; Gao WY
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2737-2745. PubMed ID: 34296570
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Rhizoma Drynariae Targets in the Treatment of Osteonecrosis of the Femoral Head based on Network Pharmacology and Experimental Verification.
Zhang Y; Weng Q; Hu T; Shen X; Han J
Curr Comput Aided Drug Des; 2023; 19(1):13-23. PubMed ID: 36201277
[TBL] [Abstract][Full Text] [Related]
6. Interventional value of total flavonoids from Rhizoma Drynariae on Cathepsin K, a potential target of osteoporosis.
Shi XL; Liu K; Wu LG
Chin J Integr Med; 2011 Jul; 17(7):556-60. PubMed ID: 21725884
[TBL] [Abstract][Full Text] [Related]
7. Total Flavonoids of Drynariae Rhizoma Prevent Bone Loss Induced by Hindlimb Unloading in Rats.
Song S; Gao Z; Lei X; Niu Y; Zhang Y; Li C; Lu Y; Wang Z; Shang P
Molecules; 2017 Jun; 22(7):. PubMed ID: 28640230
[TBL] [Abstract][Full Text] [Related]
8. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu).
Guo D; Wang J; Wang X; Luo H; Zhang H; Cao D; Chen L; Huang N
J Ethnopharmacol; 2011 Nov; 138(2):451-7. PubMed ID: 21964193
[TBL] [Abstract][Full Text] [Related]
9. Effect of
Su H; Xue H; Gao S; Yan B; Wang R; Tan G; Xu Z; Zeng L
Front Endocrinol (Lausanne); 2022; 13():930912. PubMed ID: 35983515
[TBL] [Abstract][Full Text] [Related]
10. [Research on network pharmacology of Acori Tatarinowii Rhizoma combined with Curcumae Radix in treating epilepsy].
Wang Q; Yuan LL; Zhang YL; Fan WT
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2701-2708. PubMed ID: 31359680
[TBL] [Abstract][Full Text] [Related]
11. Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.
Huang Y; Liu X; Zhao L; Li F; Xiong Z
Biomed Chromatogr; 2014 Jun; 28(6):878-84. PubMed ID: 24861758
[TBL] [Abstract][Full Text] [Related]
12. Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation.
Zhang F; Li Q; Wu J; Ruan H; Sun C; Zhu J; Song Q; Wei X; Shi Y; Zhu L
Front Endocrinol (Lausanne); 2022; 13():920931. PubMed ID: 35846330
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Rhizoma Drynariae Targets in the Treatment of Osteoarthritis Based on Network Pharmacology and Experimental Verification.
Chen GY; Liu XY; Chen JQ; Yu XB; Luo J; Yan ZR; Tao QW
Evid Based Complement Alternat Med; 2021; 2021():5233462. PubMed ID: 34840589
[TBL] [Abstract][Full Text] [Related]
14. UPLC-MS metabolomics method provides valuable insights into the effect and underlying mechanisms of Rhizoma Drynariae protecting osteoporosis.
Jiang YC; Li YF; Zhou L; Zhang DP
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122262. PubMed ID: 32682315
[TBL] [Abstract][Full Text] [Related]
15. Active components and mechanisms of total flavonoids from Rhizoma Drynariae in enhancing cranial bone regeneration: An investigation employing serum pharmacochemistry and network pharmacology approaches.
Zhao Y; Cai X; Sun J; Bi W; Yu Y
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117253. PubMed ID: 37778522
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis Based on TMT Regarding the Therapeutic Action of Rhizoma Drynariae on Rats in an Osteoporosis Model.
Su H; Yan B; Wang R; Li Z; Xu Z; Xue H; Tan G
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 38099525
[TBL] [Abstract][Full Text] [Related]
17. [Review for treatment effect and signaling pathway regulation of kidney-tonifying traditional Chinese medicine on osteoporosis].
Xiao YP; Zeng J; Jiao LN; Xu XY
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):21-30. PubMed ID: 29552807
[TBL] [Abstract][Full Text] [Related]
18. Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry.
Liu X; Zhang S; Lu X; Zheng S; Li F; Xiong Z
J Ethnopharmacol; 2012 Jan; 139(1):311-7. PubMed ID: 22120013
[TBL] [Abstract][Full Text] [Related]
19. Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry.
Lu X; Xiong Z; Li J; Zheng S; Huo T; Li F
Talanta; 2011 Jan; 83(3):700-8. PubMed ID: 21147309
[TBL] [Abstract][Full Text] [Related]
20. [High performance liquid chromatographic fingerprints of ethanol and cyclohexane extracts of Rhizoma Drynariae and quantitative analysis of index components based on principal component analysis].
Li X; Xiong Z; Yu M; Lu X; Yu X; Li F
Se Pu; 2009 Jul; 27(4):453-7. PubMed ID: 19938502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
